Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Mulé

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Immunological Investigations|June 15, 2000
Tumor vaccine strategies that employ dendritic cells and tumor lysates: experimental and clinical studiesJ J Mulé
The Journal of Clinical Investigation|March 23, 2000
Dendritic cells: at the clinical crossroadsJ J Mulé
Important Advances in Oncology|January 1, 1989
Immunotherapy with lymphokine combinationsJ J Mulé, S A Rosenberg
Journal of Leukocyte Biology|August 1, 1994
Gene therapy: current status and future prospectsW G Kerr, J J Mulé
Human Gene Therapy|April 25, 2000
Gene-modified dendritic cells for use in tumor vaccinesC J Kirk, J J Mulé
The Journal of Clinical Investigation|March 10, 2001
How much help does a vaccine-induced T-cell response need?J S Weber, J J Mulé
Progress in Clinical and Biological Research|January 1, 1987
Mechanistic aspects of successful immunotherapy of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin-2J J Mulé, S A Rosenberg
Surgery|September 1, 1985
Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2S A Rosenberg, J J Mulé
Human Gene Therapy|February 1, 1994
Experimental and clinical studies of cytokine gene-modified tumor cellsR I Tepper, J J Mulé
Cancer Research|November 24, 2001
Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunizationY Kotera, K Shimizu, J J Mulé
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Immunological Investigations|June 15, 2000
Tumor vaccine strategies that employ dendritic cells and tumor lysates: experimental and clinical studiesJ J Mulé
The Journal of Clinical Investigation|March 23, 2000
Dendritic cells: at the clinical crossroadsJ J Mulé
Important Advances in Oncology|January 1, 1989
Immunotherapy with lymphokine combinationsJ J Mulé, S A Rosenberg
Journal of Leukocyte Biology|August 1, 1994
Gene therapy: current status and future prospectsW G Kerr, J J Mulé
Human Gene Therapy|April 25, 2000
Gene-modified dendritic cells for use in tumor vaccinesC J Kirk, J J Mulé
The Journal of Clinical Investigation|March 10, 2001
How much help does a vaccine-induced T-cell response need?J S Weber, J J Mulé
Progress in Clinical and Biological Research|January 1, 1987
Mechanistic aspects of successful immunotherapy of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin-2J J Mulé, S A Rosenberg
Surgery|September 1, 1985
Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2S A Rosenberg, J J Mulé
Human Gene Therapy|February 1, 1994
Experimental and clinical studies of cytokine gene-modified tumor cellsR I Tepper, J J Mulé
Cancer Research|November 24, 2001
Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunizationY Kotera, K Shimizu, J J Mulé
Pageof 10